marijuana stocks news

Form 8-K for UNITED CANNABIS CORP

7-Jan-2015

Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financ

ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.On December 28, 2014, United Cannabis Corporation (the “Company”) executed a Royalty and Consulting Services Agreement with FoxBarry Farms, LLC, whereby FoxBarry will be the exclusive licensee and distributor of United Cannabis branded medical marijuana products in the state of California, which agreement is being filed herewith as Exhibit 10.1 and incorporated herein by reference.
Please see the press release attached as Exhibit 99.1 for further information about this agreement.

ITEM 7.01 REGULATION FD DISCLOSURE.On January 6, 2015, the Company issued a press release entitled “United Cannabis Corporation Signs Licensing Agreement for California with FoxBarry Farms Tribal Development Group.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.(a)

Financial Statements of Businesses Acquired

Not Applicable.

(b)

Pro Forma Financial Information

Not Applicable.

(c)
Shell Company Transactions

Not Applicable.

(d)

Exhibits.



Exhibit
Number       Description

  10.1       Royalty and Consulting Services Agreement between United Cannabis
             Corporation and FoxBarry Farms, LLC dated December 28, 2014

  99.1       Press Release entitled "United Cannabis Corporation Signs Licensing
             Agreement for California with FoxBarry Farms Tribal Development
             Group" (dated January 6, 2015)

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
1 comment
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Colorado Preparing To Dodge The Federal Marijuana Crackdown

A new approach is under review to protect Colorado’s marijuana industry from…

Aphria Inc. (APHA) to Announce First Quarter Fiscal 2021 Financial Results

Aphria Inc. to Announce First Quarter Fiscal 2021 Financial Results on October…

GW Pharmaceuticals (GWPH) and U.S. Subsidiary Greenwich Biosciences to Present Data on Epidiolex® (cannabidiol oral solution) at the 2018 American Academy of Neurology Annual Meeting

LONDON, April 12, 2018 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (GWPH) “GW,”…

Cannabis Science, Inc. (CBIS) Re-Appoints Mr. Melvin Foote to Its International Government Affairs Board

CBIS Re-Appoints Mr. Melvin Foote to Its International Government Affairs Board; Mr.…